BioSpace News Archive

Eli Lilly and Company reported that its Emgality met the primary and all key secondary endpoints in its Phase III CONQUER study for chronic and episodic migraine.

Sosei Group Corporation inked a strategic multi-target partnership with Takeda Pharmaceutical to find, develop and commercialize small molecules and biologics that modulate G protein-coupled receptor targets. The initial focus will be on gastrointestinal targets.

New ‘Vilnius-Made’ method reduces DNA testing costs by 90%, while the city’s long-standing tradition of life sciences further position Lithuanian Capital as emerging European hub of international scientific development

Oncoceutics, Inc., announced a collaboration with the National Cancer Institute funded Pediatric Preclinical Testing Consortium to enable tumor type selection for ONC201 clinical trials in pediatric oncology beyond diffuse midline gliomas.

Roche announced interim results from its Phase III IMvigor130 clinical trial, indicating it met its co-primary endpoint of progression-free survival. The trial evaluated the combination of Tecentriq and platinum-based chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma compared to chemotherapy alone.

Cyclone® 70 will be used as a high energy, high intensity proton “driver” for a large science project for rare isotopes

Company strengthens board ahead of trial results in type 1 diabetes patients and expansion of indications for its proprietary Imotope™ technology

The owners of Cytena GmbH have agreed to sell all Cytena shares to CELLINK AB for a purchase price of 30.25M euros.

Guardant Health, along with researchers with MD Anderson Cancer Center, the Samsung Medical Center and others, conducted a large study that showed the Guardant360 assay can accurately detect MSI.

Canada’s primary pharmaceutical lobby group, Innovative Medicines Canada, urged the Canadian government to respond to the U.S. plans before it caused drug shortages in Canada. An earlier version of its briefing called for a government ban of all drug exports “unless otherwise permitted by regulation.”